Natural Killer Cells and their use for Cancer Immunotherapy |
|
Enduring |
|
$25.00 |
Assessing adversity in immunosafety (preclinical) |
|
Enduring |
|
$25.00 |
Immunophenotyping |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.) |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Immune-related adverse events (clinical) |
|
Enduring |
|
$25.00 |
Systems Biology Applied to Immune Safety |
|
Enduring |
|
$25.00 |
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
CAR Therapy |
|
Enduring |
|
$25.00 |